Finished Dosage Forms

We are pleased to be able to offer you a broad portfolio of Finished Dosage Forms, covering all therapeutic areas and various types of technologies.

At Galenicum Axium, we focus on three different lines of work. On the one hand, more innovative and complex developments based on our know-how acquired throughout the years in different types of pharmaceutical products. On the other hand, the development of products that will become off-patent in the next 10-20 years. And, finally, the improvement of our already existing portfolio. 

Contact our team for further information on our portfolio!

ALIMENTARY TRACT AND METABOLISM

PRODUCTS

  • Dossier available

    Almagate

    Available dosages:

    1500 mg liquid stick pack

    500 mg tablets

  • Dossier available

    Canagliflozin

    Available dosages:

    100 & 300 mg tablets

  • Dossier available

    Canagliflozin/Metformin

    Available dosages:

    50/500 mg, 50/1000 mg, 150/500 mg & 150/1000 mg tablets

  • Dossier available

    Cinitapride

    Available dosages:

    1 mg tablets

  • Dossier available

    Dapagliflozin

    Available dosages:

    5 & 10 mg tablets

  • Dossier available

    Dapagliflozin/Metformin

    Available dosages:

    5/850 & 5/1000mg tablets

  • Dossier available

    Empagliflozin

    Available dosages:

    10 & 25 mg tablets

  • Dossier available

    Linagliptin

    Available dosages:

    2.5/850 & 2.5/1000mg tablets

  • Dossier available

    Linagliptin/Metformin

    Available dosages:

    2.5/850 mg & 2.5/1000 mg

  • Dossier available

    Liraglutide

    Available dosages:

    0.6, 1.2 & 1.8mg & 0.6, 1.2, 1.8, 2.4 & 3mg pre-filled cartridge pen

  • Dossier available

    Metformin

    Available dosages:

    500, 850 & 1000 mg tablets

  • Dossier available

    Semaglutide

    Available dosages:

    2mg/1.5mL (1.34 mg/mL) pre-filled cartridge pen

  • Dossier available

    Sitagliptin

    Available dosages:

    25, 50 & 100 mg tablets

  • Dossier available

    Sitagliptin/Metformin

    Available dosages:

    50/1000 mg, 50/850 mg & 50/500 mg tablets

  • Dossier available

    Vildagliptin

    Available dosages:

    50 mg tablets

  • Dossier available

    Vildagliptin/Metformin

    Available dosages:

    50/850 mg & 50/1000 mg tablets

Blood and blood forming organs

PRODUCTS

  • Dossier available

    Cilostazol

    Available dosages:

    100 mg tablets

  • Dossier available

    Dabigatran

    Available dosages:

    75, 110 & 150 mg capsules

  • Dossier available

    Eltrombopag

    Available dosages:

    12.5, 25, 50 & 75mg + 100mg tablets

  • Dossier available

    Ferric Carboxymaltose

    Available dosages:

    50mg/mL injection

Cardiovascular system

PRODUCTS

  • Dossier available

    Atorvastatin

    Available dosages:

    10, 20, 30, 40, 60 & 80 mg tablets

  • Dossier available

    Rosuvastatin

    Available dosages:

    5, 10, 20 & 40 mg tablets

Dermatologicals

PRODUCTS

  • Dossier available

    Betamethasone Valerate

    Available dosages:

    0.5 mg/g & 1 mg/g gel

  • Dossier available

    Betamethasone/Calcipotriol

    Available dosages:

    0.5 mg/g + 50 mcg/g gel

Genito urinary system

PRODUCTS

  • Dossier available

    Dutasteride

    Available dosages:

    0.5 mg soft gel capsules

  • Dossier available

    Dutasteride/Tamsulosin

    Available dosages:

    0.5/0.4 mg capsules

Anti-infectives for systemic use

PRODUCTS

  • Dossier available

    Caspofungin

    Available dosages:

    50 & 70 mg injection

  • Dossier available

    Micafungin

    Available dosages:

    50 & 100 mg injection

  • Dalbavancin

    Available dosages:

    500mg injection

  • Dossier available

    Tigecycline

    Available dosages:

    50 mg injection

  • Aztreonam

    Available dosages:

    1g & 2g injection

Antineoplastic and immunomodulating agents

PRODUCTS

  • Dossier available

    Abiraterone

    Available dosages:

    250mg & 500mg tablets

  • Dossier available

    Anagrelide

    Available dosages:

    0.5 & 1 mg capsuless

  • Dossier available

    Anastrozole

    Available dosages:

    1 mg tablets

  • Dossier available

    Apremilast

    Available dosages:

    10, 20 & 30mg tablets

  • Dossier available

    Palbociclib

    Available dosages:

    75, 100 & 125 mg capsules

  • Dossier available

    Midostaurin

    Available dosages:

    25mg soft gel capsules

  • Dossier available

    Venetoclax

    Available dosages:

    10, 50 & 100mg tablets

  • Dossier available

    Letrozole

    Available dosages:

    2.5 mg tablets

Musculo-skeletal system

PRODUCTS

  • Dossier available

    Dexketoprofen

    Available dosages:

    25 mg oral solution stick pack

    12.5 & 25 mg tablets

Nervous system

PRODUCTS

  • Dossier available

    Almotriptan

    Available dosages:

    12.5 mg tablets

  • Dossier available

    Citicoline

    Available dosages:

    500 mg/5 ml & 1 g/10 ml oral solution stick pack

  • Dossier available

    Diazepam

    Available dosages:

    10mg/2ml pre-filled syringes

    50mg/10ml vials

  • Tafamidis

    Available dosages:

    61mg & 20mg soft gel capsules

  • Dossier available

    Paracetamol

    Available dosages:

    100mg/ml oral solution 30ml, 60ml & 90ml

  • Dossier available

    Rasagiline

    Available dosages:

    1 mg tablets

  • Dossier available

    Rivastigmine

    Available dosages:

    2mg/ml oral solution 120ml

  • Edaravone

    Available dosages:

    30mg/100mL IV infusion

Respiratory system

PRODUCTS

  • Dossier available

    Azelastine

    Available dosages:

    1mg/ml nasal spray 10ml

Sensory organs

PRODUCTS

  • Dossier available

    Fluorometholone

    Available dosages:

    1mg/ml & 25mg/ml ophthalmic suspension

Various

PRODUCTS

  • Dossier available

    Sugammadex

    Available dosages:

    200 mg/2 ml & 500 mg/5 ml injection

  • Methylene blue

    Available dosages:

    50mg/10mL & 10mg/2mL injection

Thanks for reaching out. We will get back to you as soon as possible.

RESTRICTED ACCESS

The information contained in this section is aimed at the healthcare professional of the Pharmaceutical Industry, therefore, specialized training is required for its correct interpretation.

The products mentioned may have a different authorized data sheet in each country.

If you click the "accept" button, you are expressing your willingness to access the information explicitly intended for healthcare professionals.

DABIGAMAX

DEVELOPMENT OF THE FIRST GENERIC PHARMACEUTICAL SPECIALTY WITH DABIGATRAN. Decision EMC/2755/2017, dated November 20, (DOGC núm. 7508 of 30/11/2017) regarding the call for NUCLEUS OF INDUSTRIAL RESEARCH AND EXPERIMENTAL DEVELOPMENT (file number RD17-1-0006). This project has received funding from the European Union through the European Regional Development Fund (ERDF). With the collaboration from ACCIÓ.